Sudair Pharmaceutical Company
Abdullah Alhwaimil is a Regulatory Affairs Specialist at Sudair Pharmaceutical Company since January 2021, following a role as a Regulatory Affairs trainee. Prior experience includes an internship as a PharmD intern at King Khalid University Hospital from May 2019 to May 2020 and a trainee position at the Saudi Food and Drug Authority (SFDA) in June 2019. Additionally, Abdullah completed a trainee role at Nahdi Medical Co. in March and April 2017. Abdullah Alhwaimil holds a degree from King Saud University, obtained between 2014 and 2020.
Sudair Pharmaceutical Company
1 followers
Sudair pharma is a Saudi-Based company, established in 2014 for purpose of building an advanced pharmaceutical manufacturing complex to combat chronic & life threatening diseases sudair pharma vision is fulfilling the unmet needs in pharmaceutical sector in the Saudi Arabia and MENA region. and also our mission to establishing and localizing Advanced Pharmaceutical-Biologics Industrial Group (APBIG) to improve healthcare provision and the reach to latest pharmaceuticals in Saudi Arabia and MENA region through building a local specialized professional team, international partnership and affiliations. SPC owns the land in Sudair Industrial City (100 km North of Riyadh City) encompassing more than 77,000 square meter. At this manufacturing site, the land will be equitably distributed to major pharmaceutical industry groups as joint ventures to construct manufacturing facilities. sudair pharma project is divided into several stages, first stage which is the establishment of oncology medicine plant.